State of Alaska Department of Revenue’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$444K Sell
13,455
-365
-3% -$12K ﹤0.01% 1409
2025
Q1
$555K Buy
13,820
+365
+3% +$14.7K 0.01% 1313
2024
Q4
$632K Buy
13,455
+65
+0.5% +$3.05K 0.01% 1293
2024
Q3
$706K Buy
13,390
+925
+7% +$48.8K 0.01% 1243
2024
Q2
$675K Buy
12,465
+1,830
+17% +$99.1K 0.01% 1221
2024
Q1
$745K Sell
10,635
-49,687
-82% -$3.48M 0.01% 1198
2023
Q4
$5.04M Buy
60,322
+517
+0.9% +$43.2K 0.06% 357
2023
Q3
$1.76M Sell
59,805
-3,158
-5% -$93K 0.02% 683
2023
Q2
$2.05M Sell
62,963
-1,839
-3% -$60K 0.02% 648
2023
Q1
$2.28M Sell
64,802
-1,092
-2% -$38.4K 0.03% 597
2022
Q4
$3.02M Buy
65,894
+667
+1% +$30.6K 0.04% 493
2022
Q3
$3.16M Buy
65,227
+437
+0.7% +$21.2K 0.04% 449
2022
Q2
$2.55M Buy
64,790
+6,270
+11% +$246K 0.03% 541
2022
Q1
$2.15M Sell
58,520
-870
-1% -$32K 0.02% 647
2021
Q4
$2.71M Sell
59,390
-1,530
-3% -$69.7K 0.03% 582
2021
Q3
$2.18M Buy
60,920
+11,275
+23% +$403K 0.02% 673
2021
Q2
$982K Buy
49,645
+1,675
+3% +$33.1K 0.01% 1103
2021
Q1
$1.12M Sell
47,970
-7,120
-13% -$165K 0.01% 988
2020
Q4
$1.14M Sell
55,090
-10,630
-16% -$221K 0.01% 889
2020
Q3
$1.42M Buy
65,720
+9,620
+17% +$208K 0.02% 710
2020
Q2
$1.32M Buy
56,100
+1,290
+2% +$30.4K 0.02% 734
2020
Q1
$646K Buy
54,810
+10,200
+23% +$120K 0.01% 976
2019
Q4
$473K Sell
44,610
-465
-1% -$4.93K 0.01% 1328
2019
Q3
$512K Buy
45,075
+25,467
+130% +$289K 0.01% 1264
2019
Q2
$220K Buy
19,608
+1,170
+6% +$13.1K ﹤0.01% 1426
2019
Q1
$149K Buy
18,438
+205
+1% +$1.66K ﹤0.01% 1530
2018
Q4
$115K Buy
18,233
+1,564
+9% +$9.87K ﹤0.01% 1559
2018
Q3
$164K Buy
16,669
+320
+2% +$3.15K ﹤0.01% 1543
2018
Q2
$135K Hold
16,349
﹤0.01% 1558
2018
Q1
$117K Buy
16,349
+6,230
+62% +$44.6K ﹤0.01% 1542
2017
Q4
$82K Hold
10,119
﹤0.01% 1552
2017
Q3
$146K Buy
10,119
+1,070
+12% +$15.4K 0.01% 1099
2017
Q2
$109K Buy
+9,049
New +$109K 0.01% 1089